ANDA 78857, held by Pharmazone. Celecoxib.
As of Nov 15, 2026, ANDA 78857 (Celecoxib), held by Pharmazone, was first approved by FDA on Feb 11, 2015, with 5 approved supplements and 0 published complete response letters.
| Feb 11, 2015 | Original application | Approved | None posted |
| May 30, 2014 | Original application | Approved |
| Mar 9, 2022 | Supplement 13Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 7Labeling · Standard review | Approved | None posted |
| Apr 2, 2019 | Supplement 5Labeling · Standard review | Approved | None posted |
| Sep 16, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 10, 2015 | Supplement 1Manufacturing | Approved | None posted |
| Feb 11, 2015 | Original application | Approved | None posted |
| May 30, 2014 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters